For the quarter ending 2026-03-31, OPRX made $19,844K in revenue. -$495K in net income. Net profit margin of -2.49%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net revenue | 19,844 | 32,239 | 26,067 | 29,195 |
| Cost of revenues, exclusive of depreciation and amortization presented separately below | 4,912 | 8,139 | 8,551 | 10,560 |
| Gross profit | - | 24,100 | 17,516 | 18,635 |
| Sales and marketing | 4,729 | - | - | - |
| General and administrative | 3,513 | - | 14,386 | 14,372 |
| Research and development | 3,402 | - | - | - |
| Stock-based compensation | 1,828 | 1,741* | - | - |
| Goodwill impairment | - | - | 0 | - |
| Impairment charges | - | 92* | - | - |
| Depreciation and amortization | 1,064 | 1,079 | 1,080 | 1,074 |
| Other general and administrative expenses | - | 12,621* | - | - |
| Total operating expenses | - | 15,532 | 15,466 | 15,446 |
| Costs and expenses, total | 19,448 | - | - | - |
| Income (loss) from operations | 396 | 8,568 | 2,050 | 3,189 |
| Interest expense | 1,155 | 1,240 | 1,154 | 1,603 |
| Other income | 38 | 60 | 62 | 37 |
| Interest income | 77 | 84 | 91 | 90 |
| Total other expenses, net | -1,040 | -1,096 | -1,001 | -1,476 |
| Loss before provision for income taxes | -644 | 7,472 | 1,049 | 1,713 |
| Income tax benefit | -149 | 2,452 | 270 | 181 |
| Net loss | -495 | 5,020 | 779 | 1,532 |
| Basic EPS | -0.03 | 0.269 | 0.04 | 0.08 |
| Diluted EPS | -0.03 | 0.264 | 0.04 | 0.08 |
| Basic Average Shares | 18,761,622 | 18,663,531 | 18,576,199 | 18,510,834 |
| Diluted Average Shares | 18,761,622 | 19,047,671 | 19,459,877 | 19,015,496 |
OptimizeRx Corp (OPRX)
OptimizeRx Corp (OPRX)